News for Outset Medical, Inc. (OM)

Significant Transaction by PERCEPTIVE ADVISORS LLC (Trades, Portfolio) On January 8, 2025, PERCEPTIVE ADVISORS LLC (Trades, Portfolio) executed a noteworthy tra

SAN JOSE, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. ( OM) (”œOutset”), a medical technology company pioneering a first-of-its-kind tec

Outset Medical (OM) reports Q4 2024 revenue growth, improved margins, & reduced expenses. Learn about 2025 growth plans & profitability focus.

Outset Medical, Inc. (NASDAQ:OM) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ETCompany ParticipantsJim Mazzola - Head of Investor...

Outset Medical (OM) delivered earnings and revenue surprises of 13.95% and 6.05%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Outset Medical Inc (OM) is set to release its Q4 2024 earnings on Feb 19, 2025. The consensus estimate for Q4 2024 revenue is $28.47 million, and the earnings a

Outset Medical (OM) said that all of the issues cited in a warning letter from the FDA in July 2023 have been addressed. Read more here.

On December 31, 2024, FMR LLC (Trades, Portfolio) made a significant move by reducing its holdings in Outset Medical Inc (OM). The firm sold 1,102,563 shares at

Outset Medical (OM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Out

SAN JOSE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. ( OM) (”œOutset”), a medical technology company pioneering a first-of-its-kind tec

On December 31, 2024, Vanguard Group Inc executed a significant transaction involving Outset Medical Inc (OM), reducing its holdings by 35,632 shares. This adju

Outset Medical general counsel John Brottem sells $26,344 in stock

Outset Medical CFO Ahmed Nabeel sells $27,430 in stock

Today the Board of Directors (the ”œBoard”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the

Outset Medical CEO Leslie Trigg sells $26,913 in common stock

Outset medical CFO Ahmed Nabeel sells stock worth $23,515

On January 3, 2025, Durable Capital Partners LP (Trades, Portfolio) executed a noteworthy transaction by acquiring 26,609,101 shares of Outset Medical Inc (OM)

Outset Medical chair and CEO sells $13,192 in stock